These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 3363536)

  • 1. Preoperative identification of patients at high risk of deep venous thrombosis despite prophylaxis in total hip replacement.
    Rocha E; Alfaro MJ; Páramo JA; Cañadell JM
    Thromb Haemost; 1988 Feb; 59(1):93-5. PubMed ID: 3363536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postoperative changes in the plasmatic levels of tissue-type plasminogen activator and its fast-acting inhibitor--relationship to deep vein thrombosis and influence of prophylaxis.
    Páramo JA; Alfaro MJ; Rocha E
    Thromb Haemost; 1985 Oct; 54(3):713-6. PubMed ID: 3937269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prophylaxis of thromboembolic disease and platelet-related changes following total hip replacement: a comparative study of aspirin and heparin-dihydroergotamine.
    Alfaro MJ; Páramo JA; Rocha E
    Thromb Haemost; 1986 Aug; 56(1):53-6. PubMed ID: 3535158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of preoperative blood tests for predicting deep vein thrombosis after total hip replacement.
    Mindner K; Bergmann I; Sturm G; Liedloff H; Hindersin P; Gleiser W; Till U; Vogel G
    Haematologia (Budap); 1988; 21(1):47-55. PubMed ID: 3396975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of enoxaparin in prevention of deep venous thrombosis in hip and knee surgery--a comparison with the dihydroergotamine-heparin combination.
    Perhoniemi V; Vuorinen J; Myllynen P; Kivioja A; Lindevall K
    Ann Chir Gynaecol; 1996; 85(4):359-63. PubMed ID: 9014067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prophylaxis of deep vein thrombosis in high risk patients undergoing total hip replacement with low molecular weight heparin plus dihydroergotamine.
    Haas S; Stemberger A; Fritsche HM; Welzel D; Wolf H; Lechner F; Blümel G
    Arzneimittelforschung; 1987 Jul; 37(7):839-43. PubMed ID: 2823840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibrinolytic parameters in patients undergoing total hip replacement: relationship with the development of asymptomatic deep vein thrombosis and diagnostic usefulness of venous occlusion.
    Trotti R; Siragusa S; Rondanelli M; Chezzi L; Citterio A; Melzi d'Eril GV; Piovella F
    Haematologica; 1997; 82(2):178-81. PubMed ID: 9175322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Thromboembolic disease and changes in coagulation after total hip arthroplasty. Effect of prophylaxis with acetylsalicylic acid or heparin-dihydroergotamine].
    Alfaro M; Páramo JA; de Pablos J; Cañadell J; Rocha E
    Sangre (Barc); 1986; 31(2):145-55. PubMed ID: 3726711
    [No Abstract]   [Full Text] [Related]  

  • 9. Low doses of heparin and heparin dihydergot in postoperative thromboprophylaxis in gynaecological patients.
    Urlep-Salinović V; Jelatancev B; Gorisek B
    Thromb Haemost; 1994 Jul; 72(1):16-20. PubMed ID: 7974365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined dihydroergotamine and heparin prophylaxis of postoperative deep vein thrombosis: proposed mechanism of action.
    Comerota AJ; Stewart GJ; White JV
    Am J Surg; 1985 Oct; 150(4A):39-44. PubMed ID: 3901791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Optimation of postoperative prophylaxis of thrombosis in gynaecology (author's transl)].
    Adolf J; Buttermann G; Weidenbach A; Gmeineder F
    Geburtshilfe Frauenheilkd; 1978 Feb; 38(2):98-104. PubMed ID: 631536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of deep venous thrombosis following total hip replacement, using epidural analgesia.
    Christensen SW; Wille-Jørgensen P; Bjerg-Nielsen A; Kjaer L
    Acta Orthop Belg; 1989; 55(1):58-61. PubMed ID: 2801064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. United States trial of dihydroergotamine and heparin prophylaxis of deep vein thrombosis.
    DiSerio FJ; Sasahara AA
    Am J Surg; 1985 Oct; 150(4A):25-32. PubMed ID: 3901790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subcutaneous low-molecular-weight heparin vs warfarin for prophylaxis of deep vein thrombosis after hip or knee implantation. An economic perspective.
    Hull RD; Raskob GE; Pineo GF; Feldstein W; Rosenbloom D; Gafni A; Green D; Feinglass J; Trowbridge AA; Elliott CG
    Arch Intern Med; 1997 Feb; 157(3):298-303. PubMed ID: 9040296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of deep vein thrombosis after elective hip replacement surgery by preoperative clinical and haemostatic variables: the ECAT DVT Study. European Concerted Action on Thrombosis.
    Lowe GD; Haverkate F; Thompson SG; Turner RM; Bertina RM; Turpie AG; Mannucci PM
    Thromb Haemost; 1999 Jun; 81(6):879-86. PubMed ID: 10404761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dihydroergotamine/heparin in the prevention of deep-vein thrombosis after total hip replacement. A controlled, prospective, randomized multicenter trial.
    Beisaw NE; Comerota AJ; Groth HE; Merli GJ; Weitz HH; Zimmerman RC; Diserio FJ; Sasahara AA
    J Bone Joint Surg Am; 1988 Jan; 70(1):2-10. PubMed ID: 3275673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical risk factors for deep vein thrombosis after total hip and knee arthroplasty].
    Guan ZP; Lü HS; Chen YZ; Song YN; Qin XL; Jiang J
    Zhonghua Wai Ke Za Zhi; 2005 Oct; 43(20):1317-20. PubMed ID: 16271243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombin-antithrombin III complexes in the prediction of deep vein thrombosis following total hip replacement.
    Hoek JA; Nurmohamed MT; ten Cate JW; Büller HR; Knipscheer HC; Hamelynck KJ; Marti RK; Sturk A
    Thromb Haemost; 1989 Dec; 62(4):1050-2. PubMed ID: 2559485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apparent lack of synergism between heparin and dihydroergotamine in prevention of deep vein thrombosis after elective hip replacement: a randomised double-blind trial reported in conjunction with an overview of previous results.
    Gallus AS; Cade JF; Mills KW; Murphy W
    Thromb Haemost; 1992 Sep; 68(3):238-44. PubMed ID: 1440484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective double-arm study of fibrinolysis in surgical patients.
    Kosir MA; Schmittinger L; Barno-Winarski L; Duddella P; Pone M; Perales A; Lange P; Brish LK; McGee K; Beleski K; Pawlak J; Mammen E; Sajahan NP; Kozol RA
    J Surg Res; 1998 Jan; 74(1):96-101. PubMed ID: 9536981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.